Study: Stem cell transplants reduce diabetics' insulin reliance

04/14/2009 | Yahoo!

In a U.S. study, 20 of 23 patients with Type 1 diabetes did not need to take daily insulin therapy for four years after receiving transplants of bone marrow-derived stem cells. The study also found that the patients were able to maintain the increase in levels of C-peptides, an indicator for insulin production, for at least three years.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA